The 2007 WHO ClassiWcation of Tumours of the Central Nervous System

The fourth edition of the World Health Organi- zation (WHO) classiWcation of tumours of the central ner- vous system, published in 2007, lists several new entities, including angiocentric glioma, papillary glioneuronal tumour, rosette-forming glioneuronal tumour of the fourth ventricle, papillary tumour of the pineal region, pituicy- toma and spindle cell oncocytoma of the adenohypophysis. Histological variants were added if there was evidence of a diVerent age distribution, location, genetic proWle or clini- cal behaviour; these included pilomyxoid astrocytoma, ana- plastic medulloblastoma and medulloblastoma with extensive nodularity. The WHO grading scheme and the sections on genetic proWles were updated and the rhabdoid tumour predisposition syndrome was added to the list of familial tumour syndromes typically involving the nervous system. As in the previous, 2000 edition of the WHO 'Blue Book', the classiWcation is accompanied by a concise com- mentary on clinico-pathological characteristics of each tumour type. The 2007 WHO classiWcation is based on the consensus of an international Working Group of 25 pathol- ogists and geneticists, as well as contributions from more than 70 international experts overall, and is presented as the standard for the deWnition of brain tumours to the clinical oncology and cancer research communities world-wide.

[1]  E. Zackai,et al.  Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974-1994. , 1997, The Journal of pediatrics.

[2]  J. Vermeesch,et al.  Preimplantation genetic diagnosis using fluorescent in situ hybridization for cancer predisposition syndromes caused by microdeletions. , 2009, Human reproduction.

[3]  T. Tamiya,et al.  Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas , 2000, Neuroradiology.

[4]  P. Black,et al.  The prognostic significance of postoperative residual tumor in ependymoma. , 1991, Neurosurgery.

[5]  A. Tsirikos,et al.  Spinal deformity in neurofibromatosis type-1: diagnosis and treatment , 2005, European Spine Journal.

[6]  S. Pomeroy,et al.  Pediatric brain tumors. , 2003, Neurologic clinics.

[7]  H. Hameister,et al.  An isochore transition zone in the NF1 gene region is a conserved landmark of chromosome structure and function. , 2005, Genomics.

[8]  N. Ringertz Grading of gliomas. , 2009 .

[9]  B. Scheithauer,et al.  Intraventricular perineurioma: case report. , 1998, Neurosurgery.

[10]  M. Santi,et al.  Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors. , 2003, The oncologist.

[11]  I. Jacobs,et al.  Management of head and neck plexiform neurofibromas in pediatric patients with neurofibromatosis type 1. , 2005, Archives of otolaryngology--head & neck surgery.

[12]  X. Estivill,et al.  Prenatal diagnosis of sporadic neurofibromatosis type 1 (NF1) by RNA and DNA analysis of a splicing mutation , 1999, Prenatal diagnosis.

[13]  R. Garcea,et al.  SV40 and human brain tumors. , 1997, Journal of neurovirology.

[14]  D. Louis,et al.  Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. , 1997, Annals of neurology.

[15]  S. Donaldson,et al.  Astrocytoma in children: 14 years' experience at Stanford University Medical Center. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  J. Bonnin,et al.  Tumors of the Central Nervous System (I) , 1988 .

[17]  P. Liberski,et al.  Chromosomal alterations in a case of ganglioglioma. , 1995, Cancer genetics and cytogenetics.

[18]  A. von Deimling,et al.  Malignant transformation of a gangliocytoma/ganglioglioma into a glioblastoma multiforme: a molecular genetic analysis. Case report. , 2001, Journal of neurosurgery.

[19]  K. Aldape,et al.  Small cell astrocytoma: An aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma , 2004, Cancer.

[20]  B. Brownstein,et al.  Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. , 1990, Science.

[21]  L. Becker,et al.  Infratentorial ependymomas in childhood: prognostic factors and treatment. , 1990, Journal of neurosurgery.

[22]  K. Hamano,et al.  Aicardi syndrome accompanied by auditory disturbance and multiple brain tumors , 1991, Brain and Development.

[23]  P. Kleihues,et al.  More about: cell and molecular biology of simian virus 40: implications for human infections and disease. , 2000, Journal of the National Cancer Institute.

[24]  L. Kihlström,et al.  Stereotactic radiosurgery for tectal low-grade gliomas. , 1994, Acta neurochirurgica. Supplement.

[25]  M. Rosenblum,et al.  Monomorphous Angiocentric Glioma: A Distinctive Epileptogenic Neoplasm With Features of Infiltrating Astrocytoma and Ependymoma , 2005, Journal of neuropathology and experimental neurology.

[26]  P. Gerszten,et al.  Intracranial ependymomas of childhood: long-term outcome and prognostic factors. , 1995, Neurosurgery.

[27]  Roger E. Taylor,et al.  Radiotherapy for medulloblastoma in children: a perspective on current international clinical research efforts. , 2002, Medical and pediatric oncology.

[28]  A. Spiotta,et al.  Experimental therapeutic approaches to peripheral nerve tumors. , 2007, Neurosurgical focus.

[29]  R. McLendon,et al.  MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group. , 2002, Archives of pathology & laboratory medicine.

[30]  F. Giangaspero,et al.  Ependymoma with neuropil-like islands: a case report with diagnostic and histogenetic implications , 2005, Acta Neuropathologica.

[31]  Thomas Klockgether,et al.  Molecular genetic alterations in glioblastomas with oligodendroglial component , 2001, Acta Neuropathologica.

[32]  R. Garcea,et al.  Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. , 1995, Virology.

[33]  P. Devroey,et al.  Preimplantation genetic diagnosis for neurofibromatosis type 1. , 2005, Molecular human reproduction.

[34]  J. Trojanowski,et al.  TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  K. Aldape,et al.  Small Cell Architecture—A Histological Equivalent of EGFR Amplification in Glioblastoma Multiforme? , 2001, Journal of neuropathology and experimental neurology.

[36]  C. Miller,et al.  Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  K. North,et al.  Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. , 2004, Ophthalmology.

[38]  A. von Deimling,et al.  Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1 , 2001, Acta Neuropathologica.

[39]  M. Berger,et al.  Intracranial Ependymomas of Childhood: Current Management Strategies , 2000, Pediatric Neurosurgery.

[40]  Thomas E Merchant,et al.  Preliminary results from a Phase II trail of conformal radiation therapy for pediatric patients with localised low-grade astrocytoma and ependymoma. , 2002, International journal of radiation oncology, biology, physics.

[41]  R. Friedrich,et al.  Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1. , 2007, Anticancer research.

[42]  L. Rorke,et al.  Prognostic factors in childhood ependymomas. , 1990, Pediatric neurosurgery.

[43]  A. Probst,et al.  [Ganglioglioma of optic nerve in neurofibromatosis type 1. Case report and review of the literature]. , 2000, Klinische Monatsblatter fur Augenheilkunde.

[44]  L. Riffaud,et al.  Supratentorial Ependymoma in Children , 2001, Pediatric Neurosurgery.

[45]  L. Rorke,et al.  Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. , 1994, Journal of neurosurgery.

[46]  J L Kepner,et al.  Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. , 1998, The American journal of surgical pathology.

[47]  J. Nakayama,et al.  Treatment of pigmented lesions of neurofibromatosis 1 with intense pulsed–radio frequency in combination with topical application of vitamin D3 ointment , 2007, The Journal of dermatology.

[48]  V. Jay,et al.  Intracranial and spinal metastases from a ganglioglioma with unusual cytogenetic abnormalities in a patient with complex partial seizures , 1997, Child's Nervous System.

[49]  J. Blasko,et al.  Cystic cerebellar astrocytomas in childhood , 1979, Cancer.

[50]  D. Ho,et al.  Oligodendroglioma occurring after radiation therapy for pituitary adenoma. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[51]  Ulrich Hubbe,et al.  Perspectives and limitations of image-guided neurosurgery in pediatric patients , 2003, Child's Nervous System.

[52]  C. Lázaro,et al.  Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations , 2008, Human mutation.

[53]  D. Brat,et al.  Pituicytoma: Report of Two Cases and Clues Regarding Histogenesis , 2004, Neurosurgery.

[54]  L. Neder,et al.  MIB-1 labeling index in astrocytic tumors--a clinicopathologic study. , 2004, Clinical neuropathology.

[55]  D. Schiffer,et al.  Prognosis of ependymoma , 1998, Child's Nervous System.

[56]  R. Grossman,et al.  The Clinical Significance of Extracellular Matrix in Gangliogliomas , 1996, Journal of neuropathology and experimental neurology.

[57]  E. Haan,et al.  SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype , 2009, Journal of Medical Genetics.

[58]  J. Biegel,et al.  Molecular cytogenetic studies of pediatric ependymomas , 1998, Journal of Neuro-Oncology.

[59]  G. Mortier,et al.  Whole body MR imaging in neurofibromatosis type 1 , 2009 .

[60]  J. Østergaard,et al.  Neurofibromatosis von Recklinghausen type I phenotype and early onset of cancers in siblings compound heterozygous for mutations in MSH6 , 2005, American journal of medical genetics. Part A.

[61]  T. van Dyke,et al.  Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen , 1994, Molecular and cellular biology.

[62]  G. Basso,et al.  Diencephalic syndrome and disseminated juvenile pilocytic astrocytomas of the hypothalamic‐optic chiasm region , 1997, Cancer.

[63]  W Krone,et al.  An isochore transition in the NF1 gene region coincides with a switch in the extent of linkage disequilibrium. , 2000, American journal of human genetics.

[64]  J. Biegel,et al.  Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood , 2005, Journal of Neuro-Oncology.

[65]  R. Folkerth,et al.  Evidence for clonal origin of neoplastic neuronal and glial cells in gangliogliomas. , 1997, The American journal of pathology.

[66]  G. Utermann,et al.  Hypomelanosis of Ito in a girl with plexus papilloma and translocation (X;17) , 1993, Human Genetics.

[67]  B. Harris,et al.  Spinal cord glioneuronal tumor with “rosetted” neuropil islands and meningeal dissemination: a case report , 2000, Acta Neuropathologica.

[68]  R. Gibbs,et al.  Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1. , 2006, Biochemical pharmacology.

[69]  F. Collins,et al.  The neurofibromatosis type 1 gene and its protein product, neurofibromin , 1993, Neuron.

[70]  R. Siebert,et al.  Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene , 2004, Human mutation.

[71]  F. Saran Recent advances in paediatric neuro-oncology , 2002, Current opinion in neurology.

[72]  P. Kleihues,et al.  Cerebellar medullomyoblastoma with advanced neuronal differentiation and hamartomatous component , 2004, Acta Neuropathologica.

[73]  X. Estivill,et al.  Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. , 2000, Human molecular genetics.

[74]  A. Lee,et al.  Neuroophthalmological management of optic pathway gliomas. , 2007, Neurosurgical focus.

[75]  D. Figarella-Branger,et al.  Pilocytic Astrocytomas in Children: Prognostic Factors—A Retrospective Study of 80 Cases , 2003, Neurosurgery.

[76]  K. Murray,et al.  Importance of histologic condition and treatment of pediatric cerebellar astrocytoma , 1991 .

[77]  M. Souweidane,et al.  Prolonged Convection-enhanced Delivery into the Rat Brainstem , 2003, Neurosurgery.

[78]  I. Pollack,et al.  High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis. , 1996, Neurosurgery.

[79]  D. Schiffer,et al.  Medullomyoblastoma: report of two cases , 1992, Child's Nervous System.

[80]  B. Scheithauer,et al.  `Spindle Cell Oncocytoma' of the Adenohypophysis: A Tumor of Folliculostellate Cells? , 2002, The American journal of surgical pathology.

[81]  V. Blair,et al.  Radiotherapy in the treatment of low-grade astrocytomas , 1995, Child's Nervous System.

[82]  S. Bertolone,et al.  Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  O. Delattre,et al.  Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. , 1999, American journal of human genetics.

[84]  E. Bouffet,et al.  Chemotherapy for intracranial ependymomas , 1999, Child's Nervous System.

[85]  L. Rorke,et al.  Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[86]  A. Perry,et al.  Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features. , 2001, Journal of neurosurgery.

[87]  M. Nöthen,et al.  A novel splice site associated polymorphism in the tuberous sclerosis 2 (TSC2) gene may predispose to the development of sporadic gangliogliomas. , 1997, Journal of neuropathology and experimental neurology.

[88]  K. Poskitt,et al.  Duplication of 9P and hyperplasia of the choroid plexus: a pathologic, radiologic, and molecular cytogenetics study. , 1995, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association.

[89]  P. Cogen,et al.  Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system. , 1997, Cancer genetics and cytogenetics.

[90]  L. Rorke,et al.  MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[91]  Zbigniew Petrovich,et al.  THE CYBERKNIFE STEREOTACTIC RADIOSURGERY SYSTEM: DESCRIPTION, INSTALLATION, AND AN INITIAL EVALUATION OF USE AND FUNCTIONALITY , 2008, Neurosurgery.

[92]  J. Squire,et al.  MALIGNANT TRANSFORMATION IN A GANGLIOGLIOMA WITH ANAPLASTIC, NEURONAL AND ASTROCYTIC COMPONENTS: REPORT OF A CASE WITH FLOW CYTOMETRIC AND CYTOGENETIC ANALYSIS , 1993 .

[93]  J. Drake,et al.  Massive plexiform neurofibromas in childhood: natural history and management issues. , 2007, Journal of neurosurgery.

[94]  I. Ezpeleta,et al.  [Melanotic medulloblastoma. Ultrastructural and histochemical study of a case]. , 1990, Archivos de neurobiologia.

[95]  T. Ekfors,et al.  Pigmented primitive neuroectodermal tumor with multipotential differentiation in cerebellum (pigmented medullomyoblastoma). A case with light- and electron-microscopic, and immunohistochemical analysis. , 1987, Pediatric neuroscience.

[96]  R. McLendon,et al.  Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm. , 1998, The American journal of surgical pathology.

[97]  R. Garcea,et al.  DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. , 1992, The New England journal of medicine.

[98]  M E Cohen,et al.  Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. , 1993, The New England journal of medicine.

[99]  C. Fuller,et al.  Medullomyoblastoma: A radiographic and clinicopathologic analysis of six cases and review of the literature , 2004, Cancer.

[100]  P. Burger,et al.  Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. , 1999, Journal of neuropathology and experimental neurology.

[101]  V. Esposito,et al.  Radiosurgery in the management of pediatric brain tumors , 2000, Child's Nervous System.

[102]  S. Pinson,et al.  [Utility of 18 FDG positon emission tomography in detection of sarcomatous transformation in neurofibromatosis type 1]. , 2007, Annales de dermatologie et de venereologie.

[103]  M. Prados,et al.  Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma. , 1994, Journal of neurosurgery.

[104]  A. Hoischen,et al.  Angiocentric Glioma: Report of Clinico-Pathologic and Genetic Findings in 8 Cases , 2007, The American journal of surgical pathology.

[105]  Felice Giangaspero,et al.  Atypical Teratoid/Rhabdoid Tumors and Choroid Plexus Tumors: When Genetics “Surprise” Pathology , 2003, Brain pathology.

[106]  M. Hirose,et al.  Rhabdoid tumor of the kidney: a report of two cases with respective tumor markers and a specific chromosomal abnormality, del(11p13). , 1996, Medical and pediatric oncology.

[107]  J. Farmer,et al.  Pediatric brain stem gliomas: a review. , 1998, International journal of radiation oncology, biology, physics.

[108]  J. Wisoff,et al.  The impact of extent of resection in the management of malignant gliomas of childhood , 1999, Child's Nervous System.

[109]  J. Charrow,et al.  Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. , 1994, The Journal of pediatrics.

[110]  R. Perry,et al.  Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma. , 1995, British Journal of Cancer.

[111]  A. Jouvet,et al.  Papillary Tumor of the Pineal Region , 2003, The American journal of surgical pathology.

[112]  G Mortier,et al.  Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects , 2000, Human mutation.

[113]  James R. Anderson,et al.  Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Childrens Cancer Group study. , 1996, Medical and pediatric oncology.

[114]  K. Hoang-Xuan,et al.  Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. , 1999, Human molecular genetics.

[115]  X. Estivill,et al.  Molecular characterization of the breakpoints of a 12-kb deletion in the NF1 gene in a family showing germ-line mosaicism. , 1995, American journal of human genetics.

[116]  X. Estivill,et al.  Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients , 2003, Journal of medical genetics.

[117]  I. Vajtai,et al.  Spindle cell oncocytoma of the adenohypophysis: report of a case with a 16-year follow-up. , 2006, Pathology, research and practice.

[118]  L. Rorke,et al.  Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[119]  D. Seidenwurm,et al.  Angiocentric Neuroepithelial Tumor (ANET): A New Epilepsy‐Related Clinicopathological Entity with Distinctive MRI , 2005, Brain pathology.

[120]  A. Olivi,et al.  Pilocytic and Pilomyxoid Hypothalamic/Chiasmatic Astrocytomas , 2004, Neurosurgery.

[121]  A. Nirenberg,et al.  Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/Primitive neuroectodermal tumors , 1997, Cancer.

[122]  P. Marynen,et al.  Encephalocraniocutaneous lipomatosis with a mutation in the NF1 gene. , 1995, Journal of medical genetics.

[123]  I. Pollack Brain tumors in children. , 1994, The New England journal of medicine.

[124]  A P Warrington,et al.  Design and implementation of a system for treating paediatric patients with stereotactically-guided conformal radiotherapy. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[125]  L. Palma,et al.  The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases. , 2000, Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery.

[126]  M. O'Doherty,et al.  [18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[127]  A. Menezes,et al.  Three Choroid Plexus Papillomas in a Patient with Aicardi Syndrome , 2000, Pediatric Neurosurgery.

[128]  B. Rilliet,et al.  Gliomas in children: a review , 2000, Child's Nervous System.

[129]  M. O'Doherty,et al.  [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[130]  S. Franceschi,et al.  Correlation Among Pathology, Genotype, and Patient Outcomes in Glioblastoma , 2006, Journal of neuropathology and experimental neurology.

[131]  Tracey A. Cho,et al.  Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas. , 1999, Cancer research.

[132]  S. Lowe,et al.  p53-Dependent apoptosis suppresses tumor growth and progression in vivo , 1994, Cell.

[133]  C. L. Dolman Melanotic medulloblastoma , 2004, Acta Neuropathologica.

[134]  Daniel H. Kim,et al.  Neurofibromatosis-associated nerve sheath tumors. Case report and review of the literature. , 2006, Neurosurgical focus.

[135]  A. Urgesi,et al.  Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[136]  R. Lehmann,et al.  Two independent mutations in a family with neurofibromatosis type 1 (NF1). , 1999, American journal of medical genetics.

[137]  J. Biegel,et al.  Narrowing the critical region for a rhabdoid tumor locus in 22q11 , 1996, Genes, chromosomes & cancer.

[138]  E. Pasmant,et al.  SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype , 2009, Journal of Medical Genetics.

[139]  H. Kehrer-Sawatzki,et al.  Spectrum of single‐ and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients , 2006, Genes, chromosomes & cancer.

[140]  H. Bloom,et al.  Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy. , 1992, International journal of radiation oncology, biology, physics.

[141]  S. Giustini,et al.  Role of Maxillofacial Surgery in Patients With Neurofibromatosis Type I , 2007, The Journal of craniofacial surgery.

[142]  J. Biegel,et al.  Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain. , 1989, The New England journal of medicine.

[143]  J. Biegel,et al.  Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. , 1996, Journal of neurosurgery.

[144]  P. Kelly,et al.  Posterior fossa ependymomas: report of 30 cases and review of the literature. , 1991, Neurosurgery.

[145]  T. de Ravel,et al.  Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. , 2009, The Lancet. Oncology.

[146]  B. Scheithauer,et al.  The New WHO Classification of Brain Tumours , 1993, Brain pathology.

[147]  Daniel H. Kim,et al.  A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center. , 2005, Journal of neurosurgery.

[148]  J. Drake,et al.  Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. , 2000, American journal of human genetics.

[149]  M. Rosenblum,et al.  High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[150]  P. O'Connell,et al.  A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations , 1990, Cell.

[151]  Olivier Delattre,et al.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer , 1998, Nature.

[152]  M. Mizuguchi,et al.  Absence of allelic loss in cytomegalic neurons of cortical tuber in the Eker rat model of tuberous sclerosis , 2003, Acta Neuropathologica.

[153]  P. Steinbok Management and outcome of low-grade astrocytomas of the midline in children: A retrospective review. , 1994, Neurosurgery.

[154]  G. Reifenberger,et al.  Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. , 1999, The American journal of pathology.

[155]  P. Kleihues,et al.  Astrocytomas and Choroid Plexus Tumors in Two Families with Identical p53 Germline Mutations , 1998, Journal of neuropathology and experimental neurology.

[156]  Hiroyuki Yoshida,et al.  Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images. , 2009, Radiology.

[157]  K. Yohay The genetic and molecular pathogenesis of NF1 and NF2. , 2006, Seminars in pediatric neurology.

[158]  V. Levin,et al.  Management of hypothalamic gliomas in children: an analysis of 33 cases. , 1990, Neurosurgery.

[159]  J. Marks,et al.  Childhood cerebellar astrocytomas: is there a role for postoperative irradiation? , 1990, International journal of radiation oncology, biology, physics.

[160]  R. Packer,et al.  Chemotherapy for low-grade gliomas , 1999, Child's Nervous System.

[161]  J. Drake,et al.  Development of anaplastic changes in low-grade astrocytomas of childhood. , 1994, Neurosurgery.

[162]  D. Louis,et al.  Spindle cell oncocytoma of the adenohypophysis: report of two cases , 2005, Acta Neuropathologica.

[163]  Jianxiong Shen,et al.  Surgical treatment of scoliosis caused by neurofibromatosis type 1. , 2005, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[164]  R. Weksberg,et al.  Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. , 2004, Gastroenterology.

[165]  J. Graham,et al.  Microphthalmia and chorioretinal lesions in a girl with an Xp22.2-pter deletion and partial 3p trisomy: clinical observations relevant to Aicardi syndrome gene localization. , 1990, American journal of medical genetics.

[166]  D. Brat,et al.  Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. , 2001, The American journal of pathology.

[167]  D. Brat,et al.  Pituicytoma: a distinctive low-grade glioma of the neurohypophysis. , 2000, The American journal of surgical pathology.

[168]  H. Pass,et al.  Simian virus 40, poliovaccines and human tumors: a review of recent developments , 1997, Oncogene.

[169]  R. Cawthon,et al.  The neurofibromatosis type 1 gene. , 1993, Annual review of neuroscience.

[170]  A. King,et al.  Optic pathway gliomas in neurofibromatosis type 1: The effect of presenting symptoms on outcome , 2003, American journal of medical genetics. Part A.

[171]  D. Dickson,et al.  Medulloblastoma with Glial and Rhabdomyoblastic Differentiation A Myoglobin and Glial Fibrillary Acidic Protein Immunohistochemical and Ultrastructural Study , 1983, Journal of neuropathology and experimental neurology.

[172]  D. Brat,et al.  Newly Codified Glial Neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: Angiocentric Glioma, Pilomyxoid Astrocytoma and Pituicytoma , 2007, Brain pathology.

[173]  J. Bruner,et al.  Intracranial ependymoma in children: analysis of prognostic factors , 1992, Journal of Neuro-Oncology.

[174]  S. Elledge,et al.  Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease , 2003, Nature Genetics.

[175]  W F Taylor,et al.  Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. , 1984, Journal of neurosurgery.

[176]  A. Monaco,et al.  Characterisation of X; 17(q12;p 13) Translocation Breakpoints in a Female Patient with Hypomelanosis of Ito and Choroid Plexus Papilloma , 1997, European journal of human genetics : EJHG.

[177]  R. Kortmann,et al.  Preradiation chemotherapy for pediatric patients with high‐grade glioma , 2002, Cancer.

[178]  B. Scheithauer,et al.  A Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle: Infratentorial Form of Dysembryoplastic Neuroepithelial Tumor? , 2002, The American journal of surgical pathology.

[179]  I. Pollack,et al.  Chemotherapy for high-grade gliomas of childhood , 1999, Child's Nervous System.

[180]  Thomas W. Smith,et al.  Medullomyoblastoma. A histologic, immunohistochemical, and ultrastructural study , 1984, Cancer.

[181]  S. G. Cheng,et al.  c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function , 1999, Nature Genetics.

[182]  H. Budka,et al.  Rosette-forming glioneuronal tumor of the fourth ventricle , 2003, Acta Neuropathologica.

[183]  M. Jennings,et al.  Pharmacotherapy of Malignant Astrocytomas of Children and Adults , 2001, CNS drugs.

[184]  R. Lehmann,et al.  Recurrent NF1 gene mutation in a patient with oligosymptomatic neurofibromatosis type 1 (NF1). , 1999, American journal of medical genetics.

[185]  J. Zeller,et al.  Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1 , 2005, The British journal of dermatology.

[186]  L. Kluwe,et al.  Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene. , 2005, Anticancer research.

[187]  Wendy Thomson,et al.  Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. , 2005, Arthritis and rheumatism.

[188]  J. Kros,et al.  Familial occurrence of tumours of the choroid plexus. , 1991, Journal of medical genetics.

[189]  Ziv M. Williams,et al.  Value of PET in the assessment of patients with neurofibromatosis type 1. , 2007, AJR. American journal of roentgenology.

[190]  L. Rorke,et al.  Leptomeningeal dissemination of low‐grade gliomas in childhood , 1988, Neurology.

[191]  M. Walker,et al.  Choroid plexus papilloma and cysts in the Aicardi syndrome: case reports. , 1997, Pediatric neurosurgery.

[192]  W. J. Oakes,et al.  Leptomeningeal dissemination of optic pathway gliomas in three children. , 1991, American journal of ophthalmology.

[193]  P. Cogen,et al.  Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas , 1996, Genes, chromosomes & cancer.

[194]  J. Epstein,et al.  The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1 mice. , 2006, The Journal of clinical investigation.

[195]  R. Schmelzle,et al.  Resection of small plexiform neurofibromas in neurofibromatosis type 1 children , 2005, World journal of surgical oncology.

[196]  M. Nöthen,et al.  Mutational analysis of TSC1 and TSC2 genes in gangliogliomas , 2001, Neuropathology and applied neurobiology.

[197]  Denis Lacombe,et al.  Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[198]  I. Pollack,et al.  Mutism and pseudobulbar symptoms after resection of posterior fossa tumors in children: incidence and pathophysiology. , 1995, Neurosurgery.

[199]  D. Cooper,et al.  Three different pathological lesions in the NF1 gene originating de novo in a family with neurofibromatosis type 1 , 2002, Human Genetics.

[200]  M. Stratton,et al.  Cytogenetic abnormalities in human ependymomas , 1989, International journal of cancer.

[201]  B. Pollock,et al.  Childhood cancer in the united states: A geographical analysis of cases from the Pediatric Cooperative Clinical Trials Groups , 1996, Cancer.

[202]  P. Peltomäki,et al.  HNPCC mutation MLH1 P648S makes the functional protein unstable, and homozygosity predisposes to mild neurofibromatosis type 1 , 2004, Genes, chromosomes & cancer.

[203]  D. Louis Collins,et al.  Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.

[204]  F. Chabolle,et al.  Radiofrequency in the Treatment of Craniofacial Plexiform Neurofibromatosis: A Pilot Study , 2006, Plastic and reconstructive surgery.

[205]  E. Zackai,et al.  Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6‐year follow‐up , 1995, Cancer.

[206]  T. Poggio,et al.  Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.

[207]  I. Pollack The Role of Surgery in Pediatric Gliomas , 1999, Journal of Neuro-Oncology.

[208]  J. Biegel,et al.  Monosomy 22 in rhabdoid or atypical tumors of the brain. , 1990, Journal of neurosurgery.

[209]  M. Thom,et al.  Mixed glioneuronal tumour of the fourth ventricle with prominent rosette formation , 2006, Neuropathology and applied neurobiology.

[210]  J. Hirsch,et al.  Benign astrocytic and oligodendrocytic tumors of the cerebral hemispheres in children. , 1989, Journal of neurosurgery.

[211]  W Budach,et al.  Radiation induced CNS toxicity – molecular and cellular mechanisms , 2001, British Journal of Cancer.

[212]  Audrey E. Evans,et al.  The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial , 1989, Journal of Neuro-Oncology.

[213]  M. Bergmann,et al.  Dysembryoplastic neuroepithelial tumour of the cerebellum , 2004, Acta Neuropathologica.

[214]  J Boyett,et al.  Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group. , 1993, Neurosurgery.

[215]  B. O'neill,et al.  Phase II trial of pirfenidone in adults with neurofibromatosis type 1 , 2006, Neurology.

[216]  R. McLendon,et al.  Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition. , 2008, Archives of pathology & laboratory medicine.

[217]  T. Tamiya,et al.  Ganglioglioma in a patient with Turcot syndrome. Case report. , 2000, Journal of neurosurgery.

[218]  R. Prayson,et al.  Glioneuronal tumor with neuropil-like islands. , 2000, Human pathology.

[219]  AB Trovó‐Marqui,et al.  Neurofibromin: a general outlook , 2006, Clinical genetics.

[220]  P. Bey,et al.  [An exceptional variety of medulloblastoma: melanotic medulloblastoma]. , 1997, Annales de pathologie.

[221]  R. Arceci,et al.  Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[222]  K. Hoang-Xuan,et al.  Glioblastomas with an Oligodendroglial Component: A Pathological and Molecular Study , 2001, Journal of neuropathology and experimental neurology.

[223]  E. Levy-Lahad,et al.  Single-sperm analysis for haplotype construction of de-novo paternal mutations: application to PGD for neurofibromatosis type 1. , 2006, Human reproduction.

[224]  D. Viskochil,et al.  Molecular, Genetic, and Cellular Pathogenesis of Neurofibromas and Surgical Implications , 2006, Neurosurgery.

[225]  J. Hoffman New advances in brain tumor imaging , 2001, Current opinion in oncology.

[226]  C. Roberts,et al.  Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[227]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[228]  D. Coviello,et al.  The Genoa experience of prenatal diagnosis in NF1 , 2000, Prenatal diagnosis.

[229]  L. Palma,et al.  Hemispheric supratentorial astrocytomas in children. Long-term results in 29 cases. , 1981, Journal of neurosurgery.

[230]  P. Kelly,et al.  Grading of astrocytomas: A simple and reproducible method , 1988, Cancer.

[231]  W. Halliday,et al.  Thalamic tumors in children. Long-term follow-up and treatment guidelines. , 1984, Journal of neurosurgery.

[232]  M. Yaniv,et al.  When the SWI/SNF complex remodels … the cell cycle , 2001, Oncogene.

[233]  M. Bilsky,et al.  A distinctive glioneuronal tumor of the adult cerebrum with neuropil-like (including "rosetted") islands: report of 4 cases. , 1999, The American journal of surgical pathology.

[234]  H. Bloom,et al.  The treatment and long-term prognosis of children with intracranial tumors: a study of 610 cases, 1950-1981. , 1990, International journal of radiation oncology, biology, physics.

[235]  I. Pollack,et al.  Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. , 1995, Journal of neurosurgery.

[236]  O. G. Dodge,et al.  Histological Typing of tumours of the Central Nervous System , 1981, British Journal of Cancer.

[237]  J. Reisch,et al.  Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[238]  A. Perry,et al.  Spindle Cell Oncocytoma of the Adenohypophysis: Report of Two Recurrent Cases , 2005, The American journal of surgical pathology.

[239]  J. Biegel,et al.  Molecular analysis of a partial deletion of 22q in a central nervous system rhabdoid tumor , 1992, Genes, chromosomes & cancer.

[240]  R. Hughes,et al.  Evaluation of 18fluorodeoxyglucose positron emission tomography (18FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1 , 2000, Journal of neurology, neurosurgery, and psychiatry.

[241]  M. Berger,et al.  Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945. , 1998, Journal of neurosurgery.

[242]  D. Ellison,et al.  Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. , 2002, The American journal of pathology.

[243]  J. Montes,et al.  Low-grade astrocytomas in children: evolving management strategies. , 1998, International journal of radiation oncology, biology, physics.

[244]  Douglas C. Miller,et al.  Deferring adjuvant therapy for totally resected intracranial ependymoma. , 1996, Pediatric neurology.

[245]  M. Maeda,et al.  Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI , 2009, Journal of Cancer Research and Clinical Oncology.

[246]  B. Korf,et al.  Superficial neurofibroma: a lesion with unique MRI characteristics in patients with neurofibromatosis type 1. , 2005, AJR. American journal of roentgenology.

[247]  Webster K. Cavenee,et al.  Pathology and genetics of tumours of the nervous system. , 2000 .

[248]  M. Clementi,et al.  Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. , 2007, Neuro-oncology.

[249]  A. Sands,et al.  Disruption of Ini1 Leads to Peri-Implantation Lethality and Tumorigenesis in Mice , 2001, Molecular and Cellular Biology.

[250]  S. Pomeroy,et al.  Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[251]  R. Packer,et al.  Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[252]  T. Merchant,et al.  Bithalamic Involvement Predicts Poor Outcome among Children with Thalamic Glial Tumors , 1998, Pediatric Neurosurgery.

[253]  E. López-Aguilar,et al.  Preirradiation ifosfamide, carboplatin and etoposide (ICE) for the treatment of high-grade astrocytomas in children , 2003, Child's Nervous System.

[254]  P F Morrison,et al.  Convection-enhanced delivery of macromolecules in the brain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[255]  K. Keyvani,et al.  Rosetted glioneuronal tumor: a case with proliferating neuronal nodules , 2001, Acta Neuropathologica.

[256]  D. Frappaz,et al.  Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.